Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Lumos Pharma Inc
LUMOCurrent price
4.37 USD
+0.05 USD (+1.16%)
Last closed
4.36 USD
Company
www.lumos-pharma.com
ISIN
US55028X1090
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
37 698 540 USD
Yield for 12 month
+40.97 %
1Y
3Y
5Y
10Y
15Y
LUMO
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of products and therapies for people with rare diseases. Its primary product candidate is LUM-201, an oral growth hormone secretagogue ibutamoren, which is in Phase III clinical trial for the treatment of idiopathic pediatric growth hormone deficiency and other rare endocrine disorders. The company has a clinical collaboration with Massachusetts General Hospital to evaluate oral LUM-201 in nonalcoholic fatty liver disease. Lumos Pharma, Inc. is headquartered in Austin, Texas. Address: 4200 Marathon Boulevard, Austin, TX, United States, 78756
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
9.69 USDP/E ratio
–Dividend Yield
–Current Year
+2 051 000 USD
Last Year
+1 523 000 USD
Current Quarter
+726 000 USD
Last Quarter
+488 000 USD
Current Year
+2 007 000 USD
Last Year
+1 523 000 USD
Current Quarter
+726 000 USD
Last Quarter
+486 000 USD
Key Figures LUMO
1 year
3 years
5 years
10 years
EBITDA
-36 462 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-69.93 %
PEG Ratio
–
Return On Equity TTM
-172.83 %
Wall Street Target Price
9.69 USD
Revenue TTM
2 051 000 USD
Book Value
0.57 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-7.4 %
Dividend Yield
–
Gross Profit TTM
1 523 000 USD
Earnings per share
-4.42 USD
Diluted Eps TTM
-4.42 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics LUMO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History LUMO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:9
Payout Ratio
–
Last Split Date
19.03.2020
Dividend Date
19.03.2020
Stock Valuation LUMO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
14.3665
Price Sales TTM
18.3806
Enterprise Value EBITDA
0.3853
Price Book MRQ
3.669
Financials LUMO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators LUMO
For 52 weeks
1.37 USD
4.58 USD
50 Day MA
3.97 USD
Shares Short Prior Month
300 199
200 Day MA
2.94 USD
Short Ratio
10.16
Shares Short
285 411
Short Percent
4.98 %
BeatStart